🔎 Trials Near Me

Home › Myelodysplastic Syndromes › Ohio › Cleveland

Pag-aaral pangklinika para sa Myelodysplastic Syndromes sa Cleveland, OH

Isang pag-aaral para sa Myelodysplastic Syndromes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Cleveland. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Nagre-recruitPhase 2
  • Case Western Reserve University, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Nagre-recruitPhase 1/2
  • Cleveland Clinic, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Nagre-recruitPhase 3
  • Cleveland clinic OH, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07422480

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

Nagre-recruitPhase 2
  • Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06904482

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Nagre-recruitPhase 1/2
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT03471260

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Nagre-recruitPhase 3
  • Cleveland Clinic - Cleveland, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06499285

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Nagre-recruitPhase 1/2
  • Cleveland Clinic, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT05308264

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

Nagre-recruitMaagang Phase 1
  • Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT04187703

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

Nagre-recruitPhase 1
  • Cleveland Clinic Cancer Center, Cleveland
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT06543381

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi ang layo
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Myelodysplastic Syndromes sa ibang lungsod

Iba pang pag-aaral sa Cleveland

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.